1.
|
Please update your financial statements pursuant to Rule 8-08 of Regulation S-X.
|
2.
|
Consistent with paragraph (3) of Schedule A to the Securities Act, please revise to provide the name, address and telephone number of a registered agent for service in the United States.
|
3.
|
Please revise to briefly describe the current state of development of your product, the timeline for the development of your product, the costs associated with achieving production, and the uncertainties as to whether you will succeed in those efforts.
|
4.
|
It appears that you do not intend to register a class of securities under Section 12 of the Exchange Act. Please include a risk factor that informs potential investors that you will be not be a fully reporting company and will only comply with the limited reporting requirements imposed on Section 15(d) registrants. Briefly explain how those reports vary from the reporting obligations imposed on Section 12 registrants.
|
5.
|
It appears reasonably likely that you will have less than three hundred record shareholders at your next fiscal year end and at the conclusion of the offering. As such, it appears that there is a significant risk that your reporting obligations under Section 15(d) of the Exchange Act will be suspended under that statutory section and that you will not be required to provide periodic reports following the Form 10-K that will be required for the fiscal year in which your registration statement becomes effective. Please include a risk factor that explains the associated risks to potential investors.
|
6.
|
We note that you have not assessed the effectiveness of your internal controls over financial reporting. In addition, you will not be required to provide management’s report on the effectiveness of your internal controls over financial reporting until your second annual report, and you will be exempt from the auditor attestation requirements concerning any such report so long as you are a smaller reporting company. Please add a risk factor or risk factors addressing the associated risks.
|
7.
|
It appears that neither of your officers have any experience with your proposed business. Please address this in a risk factor.
|
8.
|
Please revise this risk factor and your disclosure on page 12 to state the percentage of time your officers will devote to your business. In addition, explain how your officers will resolve potential conflicts of interest that arise between you and the other businesses they manage.
|
9.
|
Please revise throughout this section to provide a detailed description of the current state of development of your programs, equipment and product-related services. If your products are not completed, revise to describe your products as “planned products,” and to include a timeline for completion and estimated costs.
|
10.
|
Please clarify your disclosure on page 17 where you state you are not currently conducting any research and development activities and you do not anticipate conducting such activities in the near future. In this regard, explain further how this statement supports the fact that through December 31, 2010, you incurred $157,300 in research and development expenses.
|
11.
|
Explain what you mean by the statement that you “have developed full software and database for such programs and intend to use this expertise to develop similar software and database programs for companies in the food and hardware industry.” Your disclosure elsewhere does not suggest that you have completed development of your product and does not describe any plans for the food and hardware industry.
|
12.
|
We note your statements that the Veriscan Program is a database for products that your retail customers sell and that the Infotouch Program divides a customer’s products by section. Your lack of revenue suggests that you do not currently have customers. If correct, please revise your disclosure to reference “potential” customers.
|
13.
|
Please revise to disclose whether your management has any contacts relevant to your proposed business.
|
14.
|
Please provide a more detailed description of your relationship with suppliers. In addition, please tell us whether you have any agreements with suppliers.
|
15.
|
We note your statement on page 19 that “[o]ther than the anticipated increases in legal and accounting costs due to the reporting requirements of becoming a reporting company, we are not aware of any other known trends, events or uncertainties, which may affect our liquidity.” Please reconcile this disclosure to your statement on page 20 where you include a discussion of the $80,000 in expenses you expect to incur to develop your software and website. Revise to clarify these apparent inconsistencies. Also revise to disclose the amount of additional costs you anticipate incurring as a result of becoming a public company.
|
16.
|
We note your disclosure on page 11, and elsewhere in your prospectus, that on April 1, 2010, you issued 77 million shares of common stock to your two founders and a consultant at a value of $77,000 for services rendered. Please tell us how you determined that this award of shares for services rendered did not constitute compensation. In the alternative, revise to provide the disclosure required by paragraphs (m) through (o) of Item 402 of Regulation S-K.
|
17.
|
For each unregistered offering, please revise to briefly state the facts relied upon to make the exemption available. See Item 701(d) of Regulation S-K.
|
18.
|
The language in undertaking A(1)(iii) varies from Item 512(a)(1)(iii) of Regulation S-K. Please revise.
|
19.
|
Please revise undertaking A(2) so that it is consistent with the language of Item 512(a)(2) of Regulation S-K.
|
20.
|
The language in undertaking A(3) varies from Item 512(a)(3) of Regulation S-K. Please revise.
|
21.
|
We note that consent of your independent registered public accounting firm references a report relating to the audit of the financial statements of “Santo Pita Corporation.” Please file a corrected consent that refers to the report of the registrant’s financial statements.
|
·
|
should the Commission or the staff, acting pursuant to delegated authority, declaring the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
|
·
|
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
|
·
|
the company may not assert staff comments and the declaration of effectiveness as a defense in any proceedings initiated by the Commission or any person under the federal securities laws of the United States.
|
Technologies Scan Corp.
|
|
/s/ Ghislaine St-Hilaire
|
|
Ghislaine St-Hilaire
|
|
President |